Copyright
©The Author(s) 2021.
World J Gastroenterol. May 21, 2021; 27(19): 2299-2311
Published online May 21, 2021. doi: 10.3748/wjg.v27.i19.2299
Published online May 21, 2021. doi: 10.3748/wjg.v27.i19.2299
Classification | Criteria |
Benign | No worrisome features: (1) Tumor size < 5 cm; (2) No infiltration; (3) Non-high nuclear grade and cellularity; (4) Mitotic activity ≤ 1/50 HPF; (5) No necrosis; and (6) No vascular invasion |
Uncertain malignant potential | Tumor with: (1) Pleomorphism/multinucleated giant cells only; or (2) Size > 5 cm only |
Aggressive behavior | Two or more worrisome features: (1) Size > 5 cm; (2) Peripheral infiltration; (3) High nuclear grade and cellularity; (4) Mitotic activity > 1/50 HPF; (5) Ischemic tumor necrosis for large tumor; and (6) Vascular invasion |
According to the WHO classification of tumors[1] | As with GISTs, the main predictors of a risk of metastatic behavior are marked nuclear atypia, diffuse pleomorphism and mitotic activity of more than 1 mitosis per 1 mm² |
- Citation: Calame P, Tyrode G, Weil Verhoeven D, Félix S, Klompenhouwer AJ, Di Martino V, Delabrousse E, Thévenot T. Clinical characteristics and outcomes of patients with hepatic angiomyolipoma: A literature review. World J Gastroenterol 2021; 27(19): 2299-2311
- URL: https://www.wjgnet.com/1007-9327/full/v27/i19/2299.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i19.2299